Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Three-dimensional Measurements of Diabetic Foot Ulcers

11 de marzo de 2019 actualizado por: Line Bisgaard Jørgensen, Odense University Hospital

Three-dimensional Measurements for Monitoring Wound Healing of Diabetic Foot Ulcers

Diabetic foot ulcers constitute an increasing health problem in Denmark concurrent with an ageing population and an increase in diabetes prevalence. Diabetic foot ulcers belong to the most serious and costly complications. Several studies have found that the size and depth of the ulcer is one of the major etiologic factors for delayed healing. Wound measurement is important in the monitoring of the wound healing process. For the last decade different 3D (three-dimensional) techniques for measuring wounds have been proposed in order to measure wound volume, but none of the technologies have been widely used. A 3D Wound Assessment Monitor (WAM) camera has been developed, which is able to measure wound size in 3D and to assess wound characteristics.

The investigators hypothesize that three-dimensional measurements of diabetic foot ulcers are feasible in the assessment of wound healing. A prospective cohort study is conducted in which newly admitted patients with a diabetic foot ulcer are included at the first visit at the multidisciplinary clinic. The patients are followed for one year or until complete wound healing, amputation or death. The four wound measurements: 2D area, 3D area, perimeter and volume are measured using the 3D-WAM camera with frequent intervals. Patient anthropometrics and wound data are collected during the study and correlated to the wound healing.

Descripción general del estudio

Descripción detallada

Method

Newly admitted patients with a diabetic foot ulcer are included at the first visit in the multidisciplinary clinic. The data mentioned below are collected at the first visit and the following examinations are performed including 3D photos. The wound size (2D area, 3D area, perimeter and volume) are estimated from the photos using the 3D-WAM camera. The wound examination is repeated after 2, 4, 8, 12, 24, 36 and 52 weeks or until healing of the wound. The wound healing is estimated using changes in wound size per time unit. Patients are treated by standard ulcer treatment methods and are unaffected by the project per se. During the trial the different methods of treatment are noted including changes from initial treatment. The variables will be quantified after one year depending on time to heal, establishment of a chronic ulcer (non-healing after one year) or an amputation has been performed.

At baseline the following patient data will be collected:

  • Demographic data: gender, age
  • Smoking habits
  • Time period between onset of wound to first visit in the multidisciplinary clinic
  • Body Mass Index
  • Comorbidity using Charlson Comorbidity Index score
  • Type of diabetes, duration of diabetes
  • Diabetic complications including retinopathy, albuminuria, coronary heart diseases and neuropathy

The following examinations will be performed at baseline:

  • Blood pressure measurement
  • Peripheral blood pressure
  • Examination for neuropathy using monofilament
  • Blood samples from patients with a diabetic foot ulcer

The clinical examination of the ulcer are performed at baseline and after 2, 4, 8, 12, 24, 36 and 52 weeks or until wound healing:

  • Size of wound (2D area, 3D area, perimeter, volume) measured using the 3D-WAM camera
  • Size of wound in 2D area using the digital imaging method with the software ImageJ
  • Location of the ulcer
  • Classification of ulcer: granulation, necrosis, epithelialisation
  • Secretory potential
  • Foot deformity
  • Bone affection - if osteitis is suspected an x-ray is taken
  • Signs of infection

The different types of ulcer treatment is registered for every ulcer:

  • Type of bandage
  • Antibiotics (local, systemic)
  • Revision (method, frequency),
  • Surgery

Effect variables

  • Wound 2D area, 3D area, perimeter and volume
  • Variation in 2D and 3D area measurements during the study period
  • Percentage change in wound size after 2, 4, 8, 12, 24, 36 and 52 weeks

Endpoints

  • Wound healing
  • Amputations
  • Chronic wound (non-healing after 1 year)
  • Death

Significance

This project seeks to clarify whether 3D photos of wounds will provide accurate structural measures to illuminate the background for delayed ulcer healing, and thereby to create platform for a more evidence based treatment algorithm.

Tipo de estudio

De observación

Inscripción (Actual)

150

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Odense, Dinamarca, 5000
        • University Centre of Wound Healing, Odense University Hospital (OUH)

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Newly admitted patients with diabetic foot ulcer to University Centre for Wound Healing, Odense University Hospital.

Descripción

Inclusion Criteria:

  • Newly admitted patients with diabetic foot ulcers
  • 18 years or older

Exclusion Criteria:

  • Superficial wound (less than 5x5 mm with no substantial loss of subcutaneous tissue)
  • Non-compliance (dementia, mental disorders)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Diabetic foot ulcers
Newly referred patients with diabetic foot ulcers from the multidisciplinary clinic: University Centre for Wound healing, Odense University Hospital, Denmark.
Three-dimensional wound measurement (2D area, 3D area, perimeter, volume) using 3D-WAM camera
Otros nombres:
  • 3D-WAM camera

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Wound healing change quantified using the 3D-WAM camera
Periodo de tiempo: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 3D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Wound healing change quantified using digital imaging method
Periodo de tiempo: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 2D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
The variability in 2D area and 3D area measurements
Periodo de tiempo: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The variability in 2D area (digital imaging method) and 3D area wound measurements (3D-WAM camera) at week 0, 2, 4, 8, 12, 24, 36 and 52 are compared
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Diabetes type is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
Type 1 and 2
Baseline until healing, amputation or chronic wound (52 weeks)
Diabetes duration is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
In years
Baseline until healing, amputation or chronic wound (52 weeks)
BMI (kg/m2) is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
kg/m2
Baseline until healing, amputation or chronic wound (52 weeks)
Charlson index score is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
In groups
Baseline until healing, amputation or chronic wound (52 weeks)
HbA1c is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
mmol/mol
Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is defined by ankle pressure below 70 mmHg and/or toe pressure below 45 mmHg
Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is measured by Semmes Weinstein monofilament examination
Baseline until healing, amputation or chronic wound (52 weeks)
Wound duration is compared to outcome of the wound
Periodo de tiempo: Baseline until healing, amputation or chronic wound (52 weeks)
In weeks
Baseline until healing, amputation or chronic wound (52 weeks)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Quality of life (Questionaires) using 36-Item Short Form Survey (SF-36) is compared to outcome of the wound
Periodo de tiempo: Baseline, 24 and 52 weeks
The higher the score the less disability
Baseline, 24 and 52 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Knud Yderstræde, MD, PhD, Department of Endocrinology, Odense University Hospital

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de agosto de 2015

Finalización primaria (Actual)

1 de diciembre de 2018

Finalización del estudio (Actual)

1 de diciembre de 2018

Fechas de registro del estudio

Enviado por primera vez

15 de abril de 2015

Primero enviado que cumplió con los criterios de control de calidad

19 de abril de 2015

Publicado por primera vez (Estimar)

22 de abril de 2015

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de marzo de 2019

Última actualización enviada que cumplió con los criterios de control de calidad

11 de marzo de 2019

Última verificación

1 de marzo de 2019

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Diabetes Mellitus, Tipo 2

3
Suscribir